[Conservative hormonal therapy for endometrial cancer]

Nihon Rinsho. 2004 Oct:62 Suppl 10:375-80.

[Article in Japanese]

Authors

Nobuyuki Susumu¹, Daisuke Aoki, Yutaka Tamada, Koji Banno, Atsushi Suzuki, Nao Suzuki, Shiro Nozawa

Affiliation

¹ Department of Obstetrics & Gynecology, Keio University School of Medicine.

PMID: 15535271

No abstract available

Publication types

Review

MeSH terms

17 alpha-Hydroxyprogesterone Caproate
Antineoplastic Agents, Hormonal / administration & dosage*
Antineoplastic Agents, Hormonal / adverse effects
Endometrial Neoplasms / drug therapy*
Endometrial Neoplasms / pathology
Female
Humans
Hydroxyprogesterones
Medroxyprogesterone Acetate / administration & dosage*
Medroxyprogesterone Acetate / adverse effects
Megestrol Acetate
Neoplasm Recurrence, Local / drug therapy
Neoplasm Staging
Treatment Outcome

Substances

Antineoplastic Agents, Hormonal
Hydroxyprogesterones
17 alpha-Hydroxyprogesterone Caproate
Medroxyprogesterone Acetate
Megestrol Acetate